3 Undervalued Health Care Providers & Services Stocks for Wednesday, November 19
Discover the top 3 undervalued Health Care Providers & Services stocks for Wednesday, November 19 based on AAII’s Stock Grades.Jenna Brashear
Stock Evaluator: The Cigna Group (CI)
736 followersThe Cigna Group CI
$280.76
-0.15
-0.05%
September 11, 2026 4:00:03 PM
EST
Volume: 1,341,924
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NYSE | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Commentary & Analysis
What You Need to Know About The Cigna Group's Q4 Earnings
The Cigna Group's fiscal Q4 earnings report was released on Thursday, October 30. Let's dive in to see if (CI) missed or beat analyst's expectations.Tudor Pop
5 Undervalued Health Care Providers & Services Stocks for Monday, October 20
Discover the top 5 undervalued Health Care Providers & Services stocks for Monday, October 20 based on AAII’s Stock Grades.Tudor Pop
Which Is a Better Investment, The Cigna Group or The Ensign Group, Inc. Stock?
Learn more about whether The Cigna Group or The Ensign Group, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Tudor Pop
Why The Cigna Group’s (CI) Stock Is Up 5.48%
As of Friday, October 03, The Cigna Group’s CI share price has surged by 5.48%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | CI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $74,188.2 | $1,872.1 | 95% |
|
| Shares Out (Mil) | 264.0 | 76.7 | 81% |
|
| Institutional Ownership | 99.6% | 87.8% | 90% |
|
| Float (Mil) | 262.9 | 56.5 | 78% |
|
| Beta | 0.32 | 0.74 | 19% |
|
| Avg Daily Volume (000s) | 1,469 | 526 | 78% |
|
| Price Change (52-week) |
(7.2%) | 79.8% | 42% |
|
| Growth | CI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 11.4% | 10.4% | 63% |
|
| Net Income (5yr) | (6.8%) | (0.2%) | 32% |
|
| EPS (5yr) | (0.7%) | 3.0% | 30 |
|
| Dividends (5yr) | 172.8% | 0.0% | 98% |
|
| Cash Flow (5yr) | (18.5%) | (17.9%) | 37% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 21 | 23 | 25 | |
| Current EPS | $7.494 | $30.509 | $33.487 | |
| Month Ago EPS | $7.502 | $30.507 | $33.474 | |
| # Rev Up | 1 | 0 | 1 | |
| # Rev Down | 0 | 1 | 0 | |
| Three Months Ago EPS | $7.623 | $30.403 | $33.468 | |
| Year/Year Chg | 19.1% | 37.6% | 67.4% | |
| Financials | CI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $282,382 | $1,504 | 100% |
|
| Net Income (TTM) (Mil) | $6,416 | $28 | 97% |
|
| EPS (TTM) | $24.310 | $0.200 | 98% |
|
| Operating Cash Flow (TTM) (Mil) | $10,277 | $162 | 98% |
|
| Net Cash Flow (TTM) (Mil) | $1,970 | $8 | 97% |
|
| Long-Term Debt (Q1) (Mil) | $29,086 | $373 | 97% |
|
| Enterprise Value (Q1) (Mil) | $98,214 | $2,343 | 96% |
|
| Valuation | CI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.74 | 2.88 | 46% |
|
| P/E | 11.6 | 25.8 | 23% |
|
| Dividend Yield | 2.2% | 0.0% | 78% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | CI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 9.1% | 27.8% | 8% |
|
| Net Margin | 2.3% | 1.3% | 39% |
|
| ROA | 4.2% | 2.2% | 68% |
|
| ROE | 15.5% | 7.2% | 72% |
|
| Liabilities to Assets | 72.7% | 60.5% | 68% |
|
| F-Score | 7 | 5 | 82% |
|
Passing Stock Screens
As of 9/11/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Neff Screen
Factors: Value, Growth
An approach using a stringent contrarian viewpoint—finding undervalued, out-of-favor stocks in the bargain basement that have an optimistic future.
| Performance Since Inception: | 14.7% |
| +/- S&P 500: | +7.2 |
